Clinical Trial

Ultradian Steroid Rhythms in Adrenal Incidentalomas

Study acronym: CHRONOMACS
Recruiting
View on ClinicalTrials.gov →
Summary
Twenty to 40% of adrenal incidentalomas are responsible for MACS (mild autonomous cortisol producing secretion). The biological tools used in current practice to explore MACS do not provide precise information on cortisol production abnormalities. This study is a comparative analysis of the dynamics/rhythmicity of interstitial cortisol and other steroid concentrations between MACS and non-secreting adenomas (ANS). Using the original and innovative U-RHYTHM system, interstitial fluid samples will be taken every 20 minutes for 24 to 48 hours from patients with MACS or non-secreting adenomas, and steroid assays will be performed in the perfusates to analyze steroid hormone production over 24 hours.
Protocol Amendment History 3 changes
critical Recruitment opened 2026-04-24
notable Primary completion moved earlier: 2027-11 -> 2027-10 2026-04-24
minor Completion moved earlier: 2027-11 -> 2027-10 2026-04-24
Trial Details
NCT Number NCT07387419
Lead Sponsor University Hospital, Bordeaux
Conditions Mild Autonomous Cortisol Secretion Adenoma, Non Secreting Adenoma
Enrollment 40 participants
Start Date 2026-04-15
Primary Completion 2027-10 (estimated)
Study Completion 2027-10 (estimated)
Updated on ClinicalTrials.gov 2026-04-23